Bernard L Kasten - Net Worth and Insider Trading

Bernard L Kasten Net Worth

The estimated net worth of Bernard L Kasten is at least $97,945 dollars as of 2024-04-24. Bernard L Kasten is the Director of Cleveland BioLabs Inc and owns about 22,516 shares of Cleveland BioLabs Inc (CBLI) stock worth over $97,945. Bernard L Kasten is also the Director of Enzo Biochem Inc and owns about 0 shares of Enzo Biochem Inc (ENZ) stock worth over $0. Details can be seen in Bernard L Kasten's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bernard L Kasten has not made any transactions after 2016-03-11 and currently still holds the listed stock(s).

Transaction Summary of Bernard L Kasten

To

Bernard L Kasten Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bernard L Kasten owns 5 companies in total, including Enzo Biochem Inc (ENZ) , Cleveland BioLabs Inc (CBLI) , and Genelink Inc (GNLKQ) among others .

Click here to see the complete history of Bernard L Kasten’s form 4 insider trades.

Insider Ownership Summary of Bernard L Kasten

Ticker Comapny Transaction Date Type of Owner
ENZ Enzo Biochem Inc 2016-03-11 director
CBLI Cleveland BioLabs Inc 2012-10-25 director
GNLKQ Genelink Inc 2012-09-01 director & CEO
SIGA SIGA Technologies Inc 2004-07-02 director & Chief Executive Officer
STAB Statera BioPharma Inc 2006-07-20 director

Bernard L Kasten Latest Holdings Summary

Bernard L Kasten currently owns a total of 2 stocks. Among these stocks, Bernard L Kasten owns 22,516 shares of Cleveland BioLabs Inc (CBLI) as of August 15, 2011, with a value of $97,945 and a weighting of 100%. Bernard L Kasten also owns 0 shares of Enzo Biochem Inc (ENZ) as of March 11, 2016, with a value of $0 and a weighting of 0%.

Latest Holdings of Bernard L Kasten

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CBLI Cleveland BioLabs Inc 2011-08-15 22,516 4.35 97,945
ENZ Enzo Biochem Inc 2016-03-11 0 1.09 0

Holding Weightings of Bernard L Kasten


Bernard L Kasten Form 4 Trading Tracker

According to the SEC Form 4 filings, Bernard L Kasten has made a total of 0 transactions in Cleveland BioLabs Inc (CBLI) over the past 5 years. The most-recent trade in Cleveland BioLabs Inc is the acquisition of 500 shares on August 15, 2011, which cost Bernard L Kasten around $25,900.

According to the SEC Form 4 filings, Bernard L Kasten has made a total of 0 transactions in Enzo Biochem Inc (ENZ) over the past 5 years. The most-recent trade in Enzo Biochem Inc is the sale of 42,782 shares on March 11, 2016, which brought Bernard L Kasten around $171,556.

Insider Trading History of Bernard L Kasten

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bernard L Kasten Trading Performance

GuruFocus tracks the stock performance after each of Bernard L Kasten's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bernard L Kasten is 2.41%. GuruFocus also compares Bernard L Kasten's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bernard L Kasten within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bernard L Kasten's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bernard L Kasten

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.98 2.41 8.16 -53.95 -38.49 -43.49
Relative Return to S&P 500(%) 10.95 -5.78 -3.6 -62.94 -50.95 -59.35

Bernard L Kasten Ownership Network

Ownership Network List of Bernard L Kasten

No Data

Ownership Network Relation of Bernard L Kasten


Bernard L Kasten Owned Company Details

What does Enzo Biochem Inc do?

Who are the key executives at Enzo Biochem Inc?

Bernard L Kasten is the director of Enzo Biochem Inc. Other key executives at Enzo Biochem Inc include 10 percent owner James G. Wolf , Chief Executive Officer Hamid Erfanian , and Interim CFO Patricia Eckert .

Enzo Biochem Inc (ENZ) Insider Trades Summary

Over the past 18 months, Bernard L Kasten made no insider transaction in Enzo Biochem Inc (ENZ). Other recent insider transactions involving Enzo Biochem Inc (ENZ) include a net purchase of 72,800 shares made by James G. Wolf , and a net purchase of 100,000 shares made by Hamid Erfanian .

In summary, during the past 3 months, insiders sold 0 shares of Enzo Biochem Inc (ENZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enzo Biochem Inc (ENZ) were sold and 172,800 shares were bought by its insiders, resulting in a net purchase of 172,800 shares.

Enzo Biochem Inc (ENZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Enzo Biochem Inc Insider Transactions

No Available Data

Bernard L Kasten Mailing Address

Above is the net worth, insider trading, and ownership report for Bernard L Kasten. Currently GuruFocus does not have mailing address information for Bernard L Kasten.

Discussions on Bernard L Kasten

No discussions yet.